Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza
In response to the establishment of environmental impact targets by the pharmaceutical industry, Lonza promotes responsible…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lonza
Lonza expands Capsule Manufacturing Capacity in India and China
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari, India and Suzhou,…
Lonza signs manufacturing agreement with Oasmia for ovarian cancer drug
Under the agreement, Lonza will provide kilogram-scale synthesis, purification and stability testing of Cantrixil, and deliver…
Moderna signs agreement with Lonza for production of new drug substance
New agreement with Lonza will increase drug substance production in Europe by the fourth quarter 2021
Bain Capital, Cinven to acquire Lonza Specialty Ingredients for $4.7 billion
Lonza is doubling down on its accelerating drug business
Lonza appoints Pierre-Alain Ruffieux as new CEO
Ruffieux is currently Head of Global Pharma Technical Operations at Roche where he and his 12,000-strong team are responsible for…
Lonza sets new goal to make Moderna COVID-19 vaccine ingredients
Moderna, which enlisted Lonza in May in a 10-year manufacturing contract, is racing with 100-plus other vaccine projects, having…
Noga Therapeutics and Lonza to develop Autologous Lentiviral Gene Therapy on the Cocoon Platform
The Cocoon Platform is a closed, highly customizable and scalable platform with minimal touchpoints, which will help Noga…
Moderna and Lonza collaborate to manufacture mRNA vaccine against COVID-19
Collaboration goal to produce up to one billion doses per year, first batches expected to be manufactured at Lonza US in July 2020
Lonza seeks drug industry veteran as CEO to sharpen pharma focus
Net profit last year was 646 million francs versus 563 million in 2018, the Basel-based company said. Sales rose 6.8 per cent to…